As the U.S. stock market grapples with political and economic uncertainty, leading to a correction in major indices like the S&P 500 and Nasdaq Composite, investors are increasingly seeking stability ...
In a report released on March 11, Steven Valiquette from Mizuho Securities maintained a Hold rating on LifeMD (LFMD – Research Report). The ...
Full Year 2024 Results Key Financial Results Revenue: US$212.5m (up 39% from FY 2023). Net ...
In a report released today, Brooks O’Neil from Lake Street maintained a Buy rating on LifeMD (LFMD – Research Report), with a price target of ...
Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Good afternoon. Thank you for joining us to discuss LifeMD, Inc.
SciSparc Ltd. SPRC shares fell 18.1% to $0.3278 in pre-market trading. SciSparc shares gained around 27% on Monday after ...
LifeMD Inc (LFMD) reports a 43% revenue increase and unveils plans for new product launches and Medicare offerings amid ...
Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...
3d
TipRanks on MSNLifeMD options imply 11.7% move in share price post-earningsPre-earnings options volume in LifeMD (LFMD) is 5.6x normal with calls leading puts 22:1. Implied volatility suggests the market is anticipating a ...
Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results